Kiniksa Pharmaceuticals International (KNSA) Accumulated Expenses (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) posted Accumulated Expenses of $46.73 million for Q2 2026, up 30.0% from $35.96 million a year earlier and up 42.6% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Accumulated Expenses (2017 - 2026) Analysis & Trends
At the end of FY2025, Kiniksa Pharmaceuticals International's Accumulated Expenses came in at $42.02 million, up 29.9% from FY2024.
- Annual Accumulated Expenses shows a five-year compound annual growth rate of 7.6% (FY2020 to FY2025).
- In prior years, Kiniksa Pharmaceuticals International's Accumulated Expenses was $32.36 million in FY2024 (+16.7%), $27.73 million in FY2023 (-7.9%), $30.11 million in FY2022 (-20.8%) and $38.03 million in FY2021 (+30.2%).
- The Q2 2026 figure stands as the highest quarterly Accumulated Expenses in data going back to Q4 2017.
- On a year-over-year basis, Accumulated Expenses has increased in each of the last three quarters, with growth averaging 7.1% over the last eight quarters.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q1 2024, with growth of 114.1%; the weakest was Q1 2025, with a decline of 50.5%.
- According to Business Quant data, Accumulated Expenses for the three prior quarters was $32.77 million (Q1 2026), $42.02 million (Q4 2025) and $30.94 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Kiniksa Pharmaceuticals International | 11.64 Bn | 10.38 Bn | 220.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.73 Mn |
| Mar 31, 2026 | 32.77 Mn |
| Dec 31, 2025 | 42.02 Mn |
| Sep 30, 2025 | 30.94 Mn |
| Jun 30, 2025 | 35.96 Mn |
| Mar 31, 2025 | 22.13 Mn |
| Dec 31, 2024 | 32.36 Mn |
| Sep 30, 2024 | 40.38 Mn |
| Jun 30, 2024 | 33.37 Mn |
| Mar 31, 2024 | 44.72 Mn |
| Dec 31, 2023 | 27.73 Mn |
| Sep 30, 2023 | 41.15 Mn |
| Jun 30, 2023 | 35.32 Mn |
| Mar 31, 2023 | 20.89 Mn |
| Dec 31, 2022 | 30.11 Mn |
| Sep 30, 2022 | 30.87 Mn |
| Jun 30, 2022 | 34.50 Mn |
| Mar 31, 2022 | 38.89 Mn |
| Dec 31, 2021 | 38.03 Mn |
| Sep 30, 2021 | 28.53 Mn |
API Access
Kiniksa Pharmaceuticals International Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();